Scientists create digital copies of diabetes patients to personalize care

NCT ID NCT07650682

Recruiting now Knowledge-focused Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study is gathering detailed metabolic data from 25 adults with insulin-dependent type 2 diabetes. After drinking a standard liquid meal, participants will have frequent blood tests to measure glucose, insulin, and other markers. They will also wear continuous glucose monitors and activity trackers at home. The goal is to build mathematical models, or 'digital twins,' that could one day help personalize diabetes management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to personalized digital models that help predict how people with type 2 diabetes respond to meals and activity, potentially improving future treatments.
What could go wrong: This is a small, early observational study (25 people) that only collects data—it does not test any treatment. The digital models may not work for everyone or lead to real-world benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN DEPENDENT DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INSULIN DEPENDENT DIABETES TYPE 2 DIABETES

Contacts and locations

Locations

Illinois Institute of Technology
RECRUITING

Chicago, Illinois, 60616, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.